Premium
Effect of an obesity prevention intervention on fruit, vegetable and whole grain intake in American Indian and Hispanic preschoolers
Author(s) -
Keane Patricia Coakley,
Davis Sally M,
Myers Orrin B,
Wold Rosemary Shaw
Publication year - 2011
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.25.1_supplement.30.3
Subject(s) - medicine , obesity , intervention (counseling) , cohort , whole grains , randomized controlled trial , added sugar , food frequency questionnaire , environmental health , nutrition education , gerontology , food science , chemistry , psychiatry
Objective The Child Health Initiative for Lifelong Eating and Exercise (CHILE) study is a randomized controlled trial to determine the efficacy of a trans‐community intervention to prevent obesity in American Indian and Hispanic children, aged 3–5 years, enrolled in rural Head Start (HS). Aims include increased fruit (F), vegetable (V) and whole grain (WG) consumption and decreased sugar‐sweetened beverage (SSB) and high‐fat food (HFF) consumption at home and HS. Methods 16 HS Centers in 16 rural New Mexico communities were randomized into either intervention [(I) n=8] or control [(C) n=8] groups employing a nested cohort design. 2,507 children were consented to participate [(I) n=1,333; (C) n=1,174]. The Block Kids 2004 FFQ, modified to include local foods, was administered at pre, mid and post‐intervention to caregivers (n=1,073) and measured dietary intake at home. Nutrition content of HS meals and snacks (n=165 days) was collected at pre and post intervention and analyzed using FIAS Millennium 1.0. Results Data collection is complete and data analysis is underway. Multi‐level mixed models are being used to test for intervention effects on F, V, SSB and HFF intake. Results are being calculated and will be reported. Conclusions Conclusions will be made based on the forthcoming results. CHILE is funded by NIDDK #R01 DK072958 ‐04. RS Wold is funded by USDHHS/NIH/NCRR/GCRC #5M01 RR00997